MX2009003484A - Azitromicina para el tratamiento de acne nodular. - Google Patents

Azitromicina para el tratamiento de acne nodular.

Info

Publication number
MX2009003484A
MX2009003484A MX2009003484A MX2009003484A MX2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A
Authority
MX
Mexico
Prior art keywords
treatment
azithromycin
nodular acne
acne
nodular
Prior art date
Application number
MX2009003484A
Other languages
English (en)
Spanish (es)
Inventor
David Wade Osborne
Gordon Jay Dow
Bhaskar Chaudhuri
Barry Calvarese
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Publication of MX2009003484A publication Critical patent/MX2009003484A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
MX2009003484A 2006-10-03 2007-09-24 Azitromicina para el tratamiento de acne nodular. MX2009003484A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne
PCT/US2007/020583 WO2008042139A2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Publications (1)

Publication Number Publication Date
MX2009003484A true MX2009003484A (es) 2009-10-26

Family

ID=39261797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003484A MX2009003484A (es) 2006-10-03 2007-09-24 Azitromicina para el tratamiento de acne nodular.

Country Status (18)

Country Link
US (2) US7704959B2 (enExample)
EP (2) EP2086552B1 (enExample)
JP (1) JP2010505827A (enExample)
KR (1) KR20090064592A (enExample)
CN (2) CN101534837B (enExample)
AT (1) ATE533496T1 (enExample)
AU (1) AU2007302663B2 (enExample)
BR (1) BRPI0719535A2 (enExample)
CA (1) CA2664673A1 (enExample)
CY (1) CY1112650T1 (enExample)
DK (1) DK2086552T3 (enExample)
ES (2) ES2574677T3 (enExample)
MX (1) MX2009003484A (enExample)
PL (2) PL2086552T3 (enExample)
PT (1) PT2086552E (enExample)
RU (1) RU2009116629A (enExample)
SI (1) SI2086552T1 (enExample)
WO (1) WO2008042139A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
CN111343991A (zh) * 2017-07-21 2020-06-26 阿尔米雷尔有限责任公司 非炎性病变的治疗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
WO2002080932A1 (en) * 2001-04-05 2002-10-17 Collagenex Pharmaceuticals, Inc. Methods of treating acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Also Published As

Publication number Publication date
DK2086552T3 (da) 2012-01-09
BRPI0719535A2 (pt) 2014-01-14
AU2007302663B2 (en) 2012-07-12
WO2008042139A3 (en) 2008-10-16
CN101534837B (zh) 2012-04-04
EP2086552A2 (en) 2009-08-12
EP2086552B1 (en) 2011-11-16
EP2086552A4 (en) 2009-11-04
SI2086552T1 (sl) 2012-01-31
PL2420240T3 (pl) 2016-10-31
WO2008042139A2 (en) 2008-04-10
HK1130667A1 (en) 2010-01-08
KR20090064592A (ko) 2009-06-19
AU2007302663A1 (en) 2008-04-10
CN102614210A (zh) 2012-08-01
US20100216732A1 (en) 2010-08-26
PL2086552T3 (pl) 2012-03-30
CA2664673A1 (en) 2008-04-10
JP2010505827A (ja) 2010-02-25
US7704959B2 (en) 2010-04-27
US20080081790A1 (en) 2008-04-03
PT2086552E (pt) 2011-12-19
RU2009116629A (ru) 2010-11-10
EP2420240A1 (en) 2012-02-22
ES2377470T3 (es) 2012-03-27
ES2574677T3 (es) 2016-06-21
EP2420240B1 (en) 2016-05-11
CN101534837A (zh) 2009-09-16
CY1112650T1 (el) 2016-02-10
ATE533496T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
WO2007095638A3 (en) Boron-containing small molecules as anti-inflammatory agents
TW200738725A (en) Unsaturated mTOR inhibitors
EP4591862A3 (en) Methods of treating hepatic encephalopathy
MX2009006481A (es) Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
WO2007127263A3 (en) Therapeutic uses of urolithins
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
WO2007145862A3 (en) Extending survival of cancer patients with elevated levels of egf or tgf-alpha
TW200618808A (en) Methods for treating diverse cancers
TNSN08400A1 (en) Organic compounds and their uses
MY150493A (en) Quinazoline derivatives
WO2008070743A3 (en) Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric isf35
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
MX2009003484A (es) Azitromicina para el tratamiento de acne nodular.
MY148651A (en) Antitumoral compounds
WO2009101199A3 (en) Treatment of acne vulgaris; rosacea and rhinophym
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
WO2010149688A3 (en) Antitumoral compounds
MY166063A (en) Intravenous antiviral treatments
MX2010002046A (es) Tratamiento de cancer de pulmon.
MX2009009777A (es) Administracion intravesical de apaziquone despues de reseccion transuretral para tratamiento de cancer.
WO2007127908A3 (en) Dihydrobenzoquinone compounds
TW200743134A (en) Exhausting apparatus
GB0620005D0 (en) Compounds
AU313836S (en) Gate lock

Legal Events

Date Code Title Description
FG Grant or registration